Ian Estepan - Mar 7, 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role: Chief Financial Officer
Signature: /s/ Cristin Rothfuss, as Attorney-in-Fact for Ian Estepan
Stock symbol: SRPT
Transactions as of: Mar 7, 2025
Transactions value $: -$394,612
Form type: 4
Date filed: 3/11/2025, 08:00 PM
Previous filing: Mar 10, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRPT	Common Stock	Options Exercise		+5.5K	+10.42%		58.3K	Mar 7, 2025	Direct	F1
transaction	SRPT	Common Stock	Tax liability	-$105K	-1.05K	-1.8%	$100.13	57.2K	Mar 10, 2025	Direct	F2
transaction	SRPT	Common Stock	Tax liability	-$289K	-2.89K	-5.05%	$100.13	54.3K	Mar 10, 2025	Direct	F3
transaction	SRPT	Common Stock	Award		+8.28K	+15.23%		62.6K	Mar 10, 2025	Direct	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SRPT	Performance Stock Units	Options Exercise	$0	-5.5K	-100%	$0.00	0	Mar 7, 2025	Common Stock	5.5K		Direct	F1
transaction	SRPT	Stock Options (right to buy)	Award	$0	+16.6K		$0.00	16.6K	Mar 10, 2025	Common Stock	16.6K	$99.69	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 7, 2022. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU.
F2	Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022.
F3	Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 7, 2022.
F4	The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
F5	Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.